Skip to content

Clinical trials

Phase 3 Dermatitis, Atopic trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 3 Country / region: Netherlands Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20111
20131
20141
20161
20187
20192
20201
20211
20222
20234
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting2
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
LEO Pharma4
Amgen3
Astellas Pharma Inc3
Regeneron Pharmaceuticals3
Almirall, S.A.2
Pfizer2
Agentschap NL1
Eli Lilly and Company1
Galderma R&D1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic27
Eczema9
Dermatitis2
Skin Diseases2
Genetic Diseases, Inborn1
Hypersensitivity1
Hypersensitivity, Immediate1
Immune System Diseases1
Pruritus1
Skin Diseases, Eczematous1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.